Magellan is looking for ways to boost its value. Since April 2018, its shares have dropped nearly 40 percent.
In response, the company intends to start a multiyear improvement plan to shore up finances.
People familiar with the plan say Magellan is considering being acquired by other companies.
Starboard has a 9.8 percent stake in the company.
Read the full report here.
More articles on pharmacy:
FTC settles with Teva over ‘pay-for-delay’ deals
Top 10 fatal or harmful prescribing errors
Civica Rx will start as middleman for drugmakers, hospitals, Bloomberg says
